Phase II study of gemcitabine in ovarian cancer.

[1]  M. Millward,et al.  A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  A Gordon,et al.  Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Neijt,et al.  Gemcitabine in cisplatin-resistant ovarian cancer. , 1996, Seminars in oncology.

[4]  P. Francis,et al.  Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel. , 1996, Gynecologic oncology.

[5]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.